Report cover image

Fertility Test Market - Global Outlook & Forecast 2022-2027

Publisher Arizton Advisory and Intelligence
Published Mar 24, 2022
Length 271 Pages
SKU # ARZ17043161

Description

Fertility Test Market - Global Outlook & Forecast 2022-2027

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Fertility Test Market Report

The growing awareness about fertility test and greater access to treatment is one of the major factors driving the global fertility test market growth. Fertility test industry is growing at a healthy rate during the forecast period.

Over the past few years, the fertility test industry has been growing at a healthy rate on account of rising awareness regarding fertility testing, increasing maternal age of women in developed and developing regions, rapidly increasing infertility population across the globe, and awareness among the adult population.

According to Arizton’s market research report the fertility test market by revenue is expected to grow at a CAGR of around 7% during the period 2022–2027.

MARKET SEGMENTATION

The Ovulation test kit segment dominate the market with high market share. Smart Phone based sperm analysis is an emerging trend in the global fertility test market. Use of AI in sprem analysis will boost the market growth

Based on distribution channels, the market is segmented into online sales channels, retail pharmacies, and hospitals pharmacies. In 2021, the online sales channel segment witnessed the highest market growth and is expected to grow at a CAGR of more than7% during the forecast period

Market Segmentation by Products
  • Ovulation Test Kits
  • Fertility Monitors
  • Sperm Test Kit
Market Segmentation by Gender
  • Male
  • Female
Market Segmentation by Distribution Channel
  • Online Sale Channels
  • Retail Pharmacies
  • Hospital Pharmacies
Market Segmentation by End-Users
  • Homecare
  • Speciality and Fertility Clinics
  • Hospitals
GEOGRAPHICAL ANALYSIS

Around 11% of North American women and 9% of men experience the fertility problem. Moreover, in the United States, 9% of men and 10% of women between the age group 15-44 years suffer from infertility problems which positively influence the market growth with driving demand for the fertility test.

Market Segmentation by Geography
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East and Africa
  • Turkey
  • Saudi Arabia
  • South Africa
VENDOR ANALYSIS

The fertility test kit manufacturers are trying to achieve a high market share with different revenue generation strategies. Some of the sperm test kit manufacturing companies include swim count, advacare, DNA Diagnostics Centre, Hamilton Thorne, Home Health, Give Legacy.These companies deliver high-quality sperm test kits in domestic and international markets, and will achieve a higher share in the upcoming time in the fertility test market.

PROMINENT VENDORS
  • AB Analitica
  • Ava AG
  • Advacare Pharma
  • Babystart Ltd.
  • Biozhena
  • Cyclotest
  • DNA Diagnostics Center
  • Give Legacy Inc
  • Exseed Health
  • Lady Technologies
  • Fertility Focus limited
  • Femometer
  • Fairhaven Health
  • Geratherm Medical
  • Hilin Life Products Inc
  • iXensor
  • LetsGetChecked
  • Medical Electronic System
  • Modern Fertility
  • OOVA
  • Piramal Pharma
  • Premom
  • Raiing Medical
  • Samplytics Technologies
  • SwimCount
  • Swiss Precision Diagnostics
  • Teco Diagnostics
  • Yesmom
  • Valley Electronics AG
THE REPORT INCLUDES:

1. The analysis of the global fertility test market provides market size and growth rate for the forecast period 2022-2027.

2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global fertility test market.

3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.

4. It offers a complete overview of market segments and the regional outlook of the global fertility test market.

5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.

Table of Contents

271 Pages
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
    4.1.1 INCLUSIONS
    4.1.2 EXCLUSIONS
    4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
    4.3.1 MARKET SEGMENTATION BY PRODUCT TYPE
    4.3.2 MARKET SEGMENTATION BY DISTRIBUTION CHANNELS
    4.3.3 MARKET SEGMENTATION BY END USER:
    4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 MARKET OPPORTUNITIES & TRENDS
8.1 TECHNOLOGICAL ADVANCES IN MALE FERTILITY TESTS
8.2 SMARTPHONE-BASED SAMPLE ANALYSIS
9 MARKET GROWTH ENABLERS
9.1 INCREASING MATERNAL AGE
9.2 SURGE IN INFERTILITY RATES WORLDWIDE
9.3 RISING AWARENESS OF FERTILITY TESTS
10 MARKET RESTRAINTS
10.1 LACK OF ACCURACY IN AVAILABLE FERTILITY TESTS
10.2 LOW AWARENESS & ACCEPTANCE OF FERTILITY TESTS
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
    11.2.1 MARKET SHARE BY GEOGRAPHY
    11.2.2 MARKET SHARE BY PRODUCTS
    11.2.3 MARKET SHARE BY GENDER
    11.2.4 MARKET SHARE BY DISTRIBUTION CHANNEL
    11.2.5 MARKET SHARE BY END USER
11.3 FIVE FORCES ANALYSIS
    11.3.1 THREAT OF NEW ENTRANTS
    11.3.2 BARGAINING POWER OF SUPPLIERS
    11.3.3 BARGAINING POWER OF BUYERS
    11.3.4 THREAT OF SUBSTITUTES
    11.3.5 COMPETITIVE RIVALRY
12 PRODUCTS
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 OVULATION TEST KITS
    12.3.1 MARKET OVERVIEW
    12.3.2 MARKET SIZE & FORECAST
    12.3.3 MARKET BY GEOGRAPHY
12.4 FERTILITY MONITORS
    12.4.1 MARKET OVERVIEW
    12.4.2 MARKET SIZE & FORECAST
    12.4.3 MARKET BY GEOGRAPHY
12.5 SPERM TEST KITS
    12.5.1 MARKET OVERVIEW
    12.5.2 MARKET SIZE & FORECAST
    12.5.3 MARKET BY GEOGRAPHY
13 GENDER
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 FEMALE
    13.3.1 MARKET OVERVIEW
    13.3.2 MARKET SIZE & FORECAST
    13.3.3 MARKET BY GEOGRAPHY
13.4 MALE
    13.4.1 MARKET OVERVIEW
    13.4.2 MARKET SIZE & FORECAST
    13.4.3 MARKET BY GEOGRAPHY
14 DISTRIBUTION CHANNELS
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 ONLINE SALE CHANNELS
    14.3.1 MARKET OVERVIEW
    14.3.2 MARKET SIZE & FORECAST
    14.3.3 MARKET BY GEOGRAPHY
14.4 RETAIL PHARMACIES
    14.4.1 MARKET OVERVIEW
    14.4.2 MARKET SIZE & FORECAST
    14.4.3 MARKET BY GEOGRAPHY
14.5 HOSPITAL PHARMACIES
    14.5.1 MARKET OVERVIEW
    14.5.2 MARKET SIZE & FORECAST
    14.5.3 MARKET BY GEOGRAPHY
15 END USERS
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 HOMECARE
    15.3.1 MARKET OVERVIEW
    15.3.2 MARKET SIZE & FORECAST
    15.3.3 MARKET BY GEOGRAPHY
15.4 SPECIALTY & FERILITY CLINICS
    15.4.1 MARKET OVERVIEW
    15.4.2 MARKET SIZE & FORECAST
    15.4.3 MARKET BY GEOGRAPHY
15.5 HOSPITALS
    15.5.1 MARKET OVERVIEW
    15.5.2 MARKET SIZE & FORECAST
    15.5.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
    16.2.1 DECLINE IN GLOBAL FEMALE FERTILITY RATE (REDUCTION PER WOMAN)
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 KEY COUNTRIES
    17.3.1 US: MARKET SIZE & FORECAST
    17.3.2 CANADA: MARKET SIZE & FORECAST
17.4 PRODUCTS
17.5 GENDER
17.6 DISTRIBUTION CHANNEL
17.7 END USERS
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 KEY COUNTRIES
    18.3.1 GERMANY: MARKET SIZE & FORECAST
    18.3.2 FRANCE: MARKET SIZE & FORECAST
    18.3.3 UK: MARKET SIZE & FORECAST
    18.3.4 ITALY: MARKET SIZE & FORECAST
    18.3.5 SPAIN: MARKET SIZE & FORECAST
18.4 PRODUCTS
18.5 GENDER
18.6 DISTRIBUTION CHANNEL
18.7 END USER
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 KEY COUNTRIES
    19.3.1 CHINA: MARKET SIZE & FORECAST
    19.3.2 JAPAN: MARKET SIZE & FORECAST
    19.3.3 INDIA: MARKET SIZE & FORECAST
    19.3.4 AUSTRALIA: MARKET SIZE & FORECAST
    19.3.5 SOUTH KOREA: MARKET SIZE & FORECAST
19.4 PRODUCTS
19.5 GENDER
19.6 DISTRIBUTION CHANNEL
19.7 END USER
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 KEY COUNTRIES
    20.3.1 BRAZIL: MARKET SIZE & FORECAST
    20.3.2 MEXICO: MARKET SIZE & FORECAST
    20.3.3 ARGENTINA: MARKET SIZE & FORECAST
20.4 PRODUCTS
20.5 GENDER
20.6 DISTRIBUTION CHANNEL
20.7 END USER
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 KEY COUNTRIES
    21.3.1 TURKEY: MARKET SIZE & FORECAST
    21.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    21.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
21.4 PRODUCTS
21.5 GENDER
21.6 DISTRIBUTION CHANNEL
21.7 END USER
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
23 COMPANY PROFILES
23.1 AB ANALITICA
    23.1.1 BUSINESS OVERVIEW
    23.1.2 PRODUCT OFFERINGS
23.2 AVA AG
    23.2.1 BUSINESS OVERVIEW
    23.2.2 PRODUCT OFFERINGS
23.3 ADVACARE PHARMA
    23.3.1 BUSINESS OVERVIEW
    23.3.2 PRODUCT OFFERINGS
23.4 BABYSTART
    23.4.1 BUSINESS OVERVIEW
    23.4.2 PRODUCT OFFERINGS
23.5 BIOZHENA
    23.5.1 BUSINESS OVERVIEW
    23.5.2 PRODUCT OFFERINGS
23.6 CYCLOTEST
    23.6.1 BUSINESS OVERVIEW
    23.6.2 PRODUCT OFFERINGS
23.7 DNA DIAGNOSTICS CENTRE
    23.7.1 BUSINESS OVERVIEW
    23.7.2 PRODUCT OFFERINGS
23.8 EXSEED HEALTH
    23.8.1 BUSINESS OVERVIEW
    23.8.2 PRODUCT OFFERINGS
23.9 FERTILITY FOCUS
    23.9.1 BUSINESS OVERVIEW
    23.9.2 PRODUCT OFFERINGS
23.10 FEMOMETER
    23.10.1 BUSINESS OVERVIEW
    23.10.2 PRODUCT OFFERINGS
23.11 FAIRHAVEN HEALTH
    23.11.1 BUSINESS OVERVIEW
    23.11.2 PRODUCT OFFERINGS
23.12 GERATHERM MEDICAL AG
    23.12.1 BUSINESS OVERVIEW
    23.12.2 PRODUCT OFFERINGS
23.13 GIVE LEGACY
    23.13.1 BUSINESS OVERVIEW
    23.13.2 PRODUCT OFFERINGS
23.14 HILIN LIFE PRODUCTS
    23.14.1 BUSINESS OVERVIEW
    23.14.2 PRODUCT OFFERINGS
23.15 IXENSOR
    23.15.1 BUSINESS OVERVIEW
    23.15.2 PRODUCT OFFERINGS
23.16 LADY TECHNOLOGIES
    23.16.1 BUSINESS OVERVIEW
    23.16.2 PRODUCT OFFERINGS
23.17 LETSGETCHECKED
    23.17.1 BUSINESS OVERVIEW
    23.17.2 PRODUCT OFFERINGS
23.18 MEDICAL ELECTRONIC SYSTEM
    23.18.1 BUSINESS OVERVIEW
    23.18.2 PRODUCT OFFERINGS
23.19 MODERN FERTILITY
<
    DD>23.19.1 BUSINESS OVERVIEW
    23.19.2 PRODUCT OFFERINGS
23.20 OOVA
    23.20.1 BUSINESS OVERVIEW
    23.20.2 PRODUCT OFFERINGS
23.21 PIRAMAL HEALTHCARE
    23.21.1 BUSINESS OVERVIEW
    23.21.2 PRODUCT OFFERINGS
23.22 PREMOM
    23.22.1 BUSINESS OVERVIEW
    23.22.2 PRODUCT OFFERINGS
23.23 QUANOVATE
    23.23.1 BUSINESS OVERVIEW
23.24 RAIING MEDICAL
    23.24.1 BUSINESS OVERVIEW
    23.24.2 PRODUCT OFFERINGS
23.25 INITO (SAMPLYTICS TECHNOLOGIES)
    23.25.1 BUSINESS OVERVIEW
    23.25.2 PRODUCT OFFERINGS
23.26 SWIMCOUNT
    23.26.1 BUSINESS OVERVIEW
    23.26.2 PRODUCT OFFERINGS
23.27 SWISS PRECISION DIAGNOSTICS
    23.27.1 BUSINESS OVERVIEW
    23.27.2 PRODUCT OFFERINGS
23.28 TECO DIAGNOSTICS
    23.28.1 BUSINESS OVERVIEW
    23.28.2 PRODUCT OFFERINGS
23.29 YESMOM
    23.29.1 BUSINESS OVERVIEW
    23.29.2 PRODUCT OFFERINGS
23.30 VALLEY ELECTRONICS AG
    23.30.1 BUSINESS OVERVIEW
    23.30.2 PRODUCT OFFERINGS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 MARKET BY GEOGRAPHY
    25.1.1 GLOBAL FERTILITY TEST MARKET BY GEOGRAPHY
25.2 MARKET BY PRODUCTS
    25.2.1 NORTH AMERICA: FERTILITY TEST MARKET BY PRODUCTS
    25.2.2 EUROPE: FERTILITY TEST MARKET BY PRODUCT
    25.2.3 APAC: FERTILITY TEST MARKET BY PRODUCTS
    25.2.4 LATIN AMERICA: FERTILITY TEST MARKET BY PRODUCTS
    25.2.5 MIDDLE EAST & AFRICA: FERTILITY TEST MARKET BY PRODUCTS
25.3 MARKET BY GENDER
    25.3.1 NORTH AMERICA: FERTILITY TEST MARKET BY GENDER
    25.3.2 EUROPE: FERTILITY TEST MARKET BY GENDER
    25.3.3 APAC: FERTILITY TEST MARKET BY GENDER
    25.3.4 LATIN AMERICA: FERTILITY TEST MARKET BY GENDER
    25.3.5 MIDDLE EAST & AFRICA: FERTILITY TEST MARKET BY GENDER
25.4 MARKET BY DISTRIBUTION CHANNEL
    25.4.1 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNELS
    25.4.2 EUROPE: MARKET BY DSTRIBUTION CHANNELS
    25.4.3 APAC: MARKET BY DISTRIBUTION CHANNELS
    25.4.4 LATIN AMERICA: MARKET BY DSTRIBUTION CHANNELS
    25.4.5 MIDDLE EAST & AFRICA: MARKET BY DSTRIBUTION CHANNELS
25.5 MARKET BY END USER
    25.5.1 NORTH AMERICA: MARKET BY END USER
    25.5.2 EUROPE: MARKET BY END USER
    25.5.3 APAC: MARKET BY END USER
    25.5.4 LATINAMERICA: MARKET BY END USER
    25.5.5 MIDDLE EAST & AFRICA: MARKET BY END USER
25.6 MARKET BY GEOGRAPHY
    25.6.1 OVULATION TEST KIT MARKET BY GEOGRAPHY
    25.6.2 FERTILITY MONITORS MARKET BY GEOGRAPHY
    25.6.3 SPERM TEST KIT MARKET BY GEOGRAPHY
    25.6.4 FEMALE: MARKET BY GEOGRAPHY
    25.6.5 MALE: MARKET BY GEOGRAPHY
    25.6.6 ONLINE SALES CHANNELS: MARKET BY GEOGRAPHY
    25.6.7 RETAIL PHARMACIES: MARKET BY GEOGRAPHY
    25.6.8 HOSPITAL PHARMACIES: MARKET BY GEOGRAPHY
    25.6.9 HOMECARE: MARKET BY GEOGRAPHY
    25.6.10 SPECIALTY & FERTILITY CLINICS: MARKET BY GEOGRAPHY
    25.6.11 HOSPITAL: MARKET BY GEOGRAPHY
26 APPENDIX
26.1 ABBREVIATIONS

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us